Outcome of Board meeting held on May 30, 2025, w.r.t approval of Audited Financial Results for the quarter and year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 4.4 pts less than its Other Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Kothari Fermentation & Biochem approved audited standalone financial results for Q4 FY25 and the full year ended March 31, 2025, with an unmodified (clean) audit opinion from Kothari Kuldeep & Co. Revenue from operations grew to Rs. 11,423.10 lakhs in FY25 from Rs. 10,888.09 lakhs in FY24, up about 4.9%. The company reported a major turnaround — net profit of Rs. 50.99 lakhs in FY25 versus a loss of Rs. 491.15 lakhs in FY24 — while Q4 FY25 PAT rose to Rs. 105.13 lakhs from Rs. 86.96 lakhs. EPS swung to Rs. 0.54 from a loss of Rs. 3.27. Operating cash flow was healthy at Rs. 1,070.32 lakhs (vs Rs. 863.24 lakhs prior year), and total borrowings declined. Business continues to operate in a single segment (Yeast), with a cattle feed extension noted.
Positive for shareholders — the company swung from a net loss to a small profit, posted positive operating cash flow, reduced debt, and secured a clean audit. While FY revenue growth was modest, the bottom-line turnaround and stable operations should support sentiment, though the absolute profit remains thin relative to revenue.